Patrick A. Kupelian

Q: What Schools Are Affiliated With Patrick A. Kupelian

Patrick A. Kupelian is affiliated with the following schools: University of California, Los Angeles, University of Helsinki

Patrick A. Kupelian's AcademicInfluence.com Rankings

Patrick A. Kupelian

Philosophy

#8484

World Rank

#11874

Historical Rank

Logic

#5513

World Rank

#6918

Historical Rank

philosophy Degrees

Download Badge

Philosophy

Why Is Patrick A. Kupelian Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Patrick A. Kupelian's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Salvage radiotherapy for recurrent prostate cancer after radical prostatectomy. (2004) (516)
Multi-institutional clinical experience with the Calypso System in localization and continuous, real-time monitoring of the prostate gland during external radiotherapy. (2007) (491)
Radical prostatectomy, external beam radiotherapy <72 Gy, external beam radiotherapy > or =72 Gy, permanent seed implantation, or combined seeds/external beam radiotherapy for stage T1-T2 prostate cancer. (2002) (460)
Target localization and real-time tracking using the Calypso 4D localization system in patients with localized prostate cancer. (2006) (432)
Stereotactic body radiotherapy for localized prostate cancer: pooled analysis from a multi-institutional consortium of prospective phase II trials. (2013) (401)
A preoperative nomogram identifying decreased risk of positive pelvic lymph nodes in patients with prostate cancer. (2003) (393)
Hypofractionated intensity-modulated radiotherapy (70 Gy at 2.5 Gy per fraction) for localized prostate cancer: Cleveland Clinic experience. (2003) (373)
Observations on real-time prostate gland motion using electromagnetic tracking. (2008) (371)
Cerium oxide nanoparticles protect gastrointestinal epithelium from radiation-induced damage by reduction of reactive oxygen species and upregulation of superoxide dismutase 2. (2010) (325)
Pretreatment nomogram for predicting the outcome of three-dimensional conformal radiotherapy in prostate cancer. (2000) (318)
Comparative analysis of prostate‐specific antigen free survival outcomes for patients with low, intermediate and high risk prostate cancer treatment by radical therapy. Results from the Prostate Cancer Results Study Group (2012) (312)
Protection from radiation-induced pneumonitis using cerium oxide nanoparticles. (2009) (272)
Long-term multi-institutional analysis of stage T1-T2 prostate cancer treated with radiotherapy in the PSA era. (2003) (270)
Reduced-dose radiotherapy for human papillomavirus-associated squamous-cell carcinoma of the oropharynx: a single-arm, phase 2 study. (2017) (239)
Radical Prostatectomy, External Beam Radiotherapy, or External Beam Radiotherapy With Brachytherapy Boost and Disease Progression and Mortality in Patients With Gleason Score 9-10 Prostate Cancer (2018) (221)
Comparison of the efficacy of local therapies for localized prostate cancer in the prostate-specific antigen era: a large single-institution experience with radical prostatectomy and external-beam radiotherapy. (2002) (215)
Influence of intrafraction motion on margins for prostate radiotherapy. (2006) (212)
Performance characterization of megavoltage computed tomography imaging on a helical tomotherapy unit. (2005) (208)
Defining sexual outcomes after treatment for localized prostate carcinoma (2002) (207)
International validation of a preoperative nomogram for prostate cancer recurrence after radical prostatectomy. (2002) (205)
Stage T1-2 prostate cancer: a multivariate analysis of factors affecting biochemical and clinical failures after radical prostatectomy. (1997) (203)
Correlation of clinical and pathologic factors with rising prostate-specific antigen profiles after radical prostatectomy alone for clinically localized prostate cancer. (1996) (201)
Comparison of alternative biochemical failure definitions based on clinical outcome in 4839 prostate cancer patients treated by external beam radiotherapy between 1986 and 1995. (2003) (201)
Association between a CYP3A4 genetic variant and clinical presentation in African-American prostate cancer patients. (1999) (198)
Hypofractionated intensity-modulated radiotherapy (70 gy at 2.5 Gy per fraction) for localized prostate cancer: long-term outcomes. (2005) (198)
Serial megavoltage CT imaging during external beam radiotherapy for non-small-cell lung cancer: observations on tumor regression during treatment. (2005) (189)
Health-related quality of life after stereotactic body radiation therapy for localized prostate cancer: results from a multi-institutional consortium of prospective trials. (2013) (189)
Assessment of parotid gland dose changes during head and neck cancer radiotherapy using daily megavoltage computed tomography and deformable image registration. (2008) (187)
Monotherapy for stage T1-T2 prostate cancer: radical prostatectomy, external beam radiotherapy, or permanent seed implantation. (2004) (184)
PSA nadir predicts biochemical and distant failures after external beam radiotherapy for prostate cancer: a multi-institutional analysis. (2004) (183)
The use of megavoltage CT (MVCT) images for dose recomputations (2005) (183)
Long-term Outcomes of Stereotactic Body Radiotherapy for Low-Risk and Intermediate-Risk Prostate Cancer (2019) (171)
Characterization and use of EBT radiochromic film for IMRT dose verification. (2006) (168)
Pretreatment nomogram that predicts 5-year probability of metastasis following three-dimensional conformal radiation therapy for localized prostate cancer. (2003) (165)
Initial experience with megavoltage (MV) CT guidance for daily prostate alignments. (2005) (162)
Biochemical failure does not predict overall survival after radical prostatectomy for localized prostate cancer: 10-year results. (1999) (162)
Deformable registration of the planning image (kVCT) and the daily images (MVCT) for adaptive radiation therapy (2006) (160)
Intraprostatic fiducials for localization of the prostate gland: monitoring intermarker distances during radiation therapy to test for marker stability. (2005) (157)
Comparison of ultrasound and implanted seed marker prostate localization methods: Implications for image-guided radiotherapy. (2006) (152)
Daily variations in delivered doses in patients treated with radiotherapy for localized prostate cancer. (2006) (151)
Declining rates of extracapsular extension after radical prostatectomy: evidence for continued stage migration. (1999) (149)
Preliminary observations on biochemical relapse-free survival rates after short-course intensity-modulated radiotherapy (70 Gy at 2.5 Gy/fraction) for localized prostate cancer. (2002) (141)
4π non-coplanar liver SBRT: a novel delivery technique. (2013) (139)
Outcome in elderly patients undergoing definitive surgery and radiation therapy for supratentorial glioblastoma multiforme at a tertiary care institution. (1998) (138)
American Society for Therapeutic Radiology and Oncology (ASTRO) and American College of Radiology (ACR) practice guidelines for image-guided radiation therapy (IGRT). (2010) (136)
Improved biochemical relapse-free survival with increased external radiation doses in patients with localized prostate cancer: the combined experience of nine institutions in patients treated in 1994 and 1995. (2003) (136)
Evaluation of image-guidance protocols in the treatment of head and neck cancers. (2007) (133)
Short-course intensity-modulated radiotherapy for localized prostate cancer with daily transabdominal ultrasound localization of the prostate gland. (2000) (133)
Importance of high radiation doses (72 Gy or greater) in the treatment of stage T1-T3 adenocarcinoma of the prostate. (2000) (132)
Utilizing time‐driven activity‐based costing to understand the short‐ and long‐term costs of treating localized, low‐risk prostate cancer (2015) (129)
Definitions of biochemical failure that best predict clinical failure in patients with prostate cancer treated with external beam radiation alone: a multi-institutional pooled analysis. (2005) (129)
Extent of extracapsular extension in localized prostate cancer. (2000) (127)
External beam radiotherapy versus radical prostatectomy for clinical stage T1-2 prostate cancer: therapeutic implications of stratification by pretreatment PSA levels and biopsy Gleason scores. (1997) (127)
Image-guided radiotherapy for localized prostate cancer: treating a moving target. (2008) (126)
The use of treatments for erectile dysfunction among survivors of prostate carcinoma (2002) (124)
A technique for adaptive image-guided helical tomotherapy for lung cancer. (2006) (124)
4π noncoplanar stereotactic body radiation therapy for centrally located or larger lung tumors. (2013) (121)
Evaluation of geometric changes of parotid glands during head and neck cancer radiotherapy using daily MVCT and automatic deformable registration. (2008) (120)
Review of image-guided radiation therapy (2007) (119)
Continuing trends in pathological stage migration in radical prostatectomy specimens. (2004) (119)
Short-course intensity-modulated radiotherapy (70 GY at 2.5 GY per fraction) for localized prostate cancer: preliminary results on late toxicity and quality of life. (2001) (118)
Predictive factors for late genitourinary and gastrointestinal toxicity in patients with prostate cancer treated with adjuvant or salvage radiotherapy. (2005) (118)
A multi-institutional matched-control analysis of adjuvant and salvage postoperative radiation therapy for pT3-4N0 prostate cancer. (2005) (109)
Higher than standard radiation doses (> or =72 Gy) with or without androgen deprivation in the treatment of localized prostate cancer. (2000) (109)
Evaluation of image-guidance strategies in the treatment of localized prostate cancer. (2008) (107)
Magnetic resonance-guided adaptive radiotherapy: a solution to the future. (2014) (106)
Family history of prostate cancer in patients with localized prostate cancer: an independent predictor of treatment outcome. (1997) (103)
The role of overall treatment time in the outcome of radiotherapy of prostate cancer: an analysis of biochemical failure in 4839 men treated between 1987 and 1995. (2010) (101)
Impact of biochemical failure on overall survival after radiation therapy for localized prostate cancer in the PSA era. (2002) (100)
Evaluation of an infrared camera and X-ray system using implanted fiducials in patients with lung tumors for gated radiation therapy. (2006) (97)
Use of different definitions of biochemical failure after external beam radiotherapy changes conclusions about relative treatment efficacy for localized prostate cancer. (2006) (96)
Three-dimensional prostate position estimation with a single x-ray imager utilizing the spatial probability density (2008) (91)
Optically guided patient positioning techniques. (2005) (90)
An endorectal balloon reduces intrafraction prostate motion during radiotherapy. (2012) (88)
Patient dose from megavoltage computed tomography imaging. (2008) (88)
Evaluation of high ipsilateral subventricular zone radiation therapy dose in glioblastoma: a pooled analysis. (2013) (86)
Implantation and stability of metallic fiducials within pulmonary lesions. (2007) (86)
Clinical Outcomes for Patients with Gleason Score 9-10 Prostate Adenocarcinoma Treated With Radiotherapy or Radical Prostatectomy: A Multi-institutional Comparative Analysis. (2017) (81)
Recurrence‐free survival rates after external‐beam radiotherapy for patients with clinical T1–T3 prostate carcinoma in the prostate‐specific antigen era (2004) (81)
Hypofractionation for Prostate Cancer (2009) (79)
Real-time tumor tracking in the lung using an electromagnetic tracking system. (2013) (78)
Effect of increasing radiation doses on local and distant failures in patients with localized prostate cancer. (2008) (77)
Impact of image guidance on outcomes after external beam radiotherapy for localized prostate cancer. (2008) (77)
Outcomes for intermediate risk prostate cancer: are there advantages for surgery, external radiation, or brachytherapy? (2009) (75)
Prediction of intrafraction prostate motion: accuracy of pre- and post-treatment imaging and intermittent imaging. (2009) (75)
Familial prostate cancer: a different disease? (1997) (73)
Results of linear accelerator‐based stereotactic radiosurgery for recurrent and newly diagnosed acoustic neuromas (2000) (73)
Evaluation of two tomotherapy-based techniques for the delivery of whole-breast intensity-modulated radiation therapy. (2006) (72)
Treatment outcome for patients with primary nonsmall-cell lung cancer and synchronous brain metastasis. (1999) (70)
Dose/Volume Relationship of Late Rectal Bleeding After External Beam Radiotherapy for Localized Prostate Cancer: Absolute or Relative Rectal Volume? (2001) (69)
An evaluation of intrafraction motion of the prostate in the prone and supine positions using electromagnetic tracking. (2011) (68)
Comparison of biochemical relapse-free survival between primary Gleason score 3 and primary Gleason score 4 for biopsy Gleason score 7 prostate cancer. (2009) (67)
Sexuality and Health-Related Quality of Life After Prostate Cancer in African-American and White Men Treated for Localized Disease (2004) (65)
Comparison of the efficacy of local therapies for localized prostate cancer in the prostate-specific antigen era: a large single-institution experience with radical prostatectomy and external-beam radiotherapy (2003) (64)
Seeking Help for Erectile Dysfunction After Treatment for Prostate Cancer (2004) (63)
Initial dissection of the lateral fascia reduces the positive margin rate in radical prostatectomy. (1998) (61)
4π noncoplanar stereotactic body radiation therapy for head-and-neck cancer: potential to improve tumor control and late toxicity. (2014) (60)
Validation study of the accuracy of a postoperative nomogram for recurrence after radical prostatectomy for localized prostate cancer. (2002) (58)
Dosimetric evaluation of a novel polymer gel dosimeter for proton therapy. (2010) (58)
Biochemical and clinical significance of the posttreatment prostate‐specific antigen bounce for prostate cancer patients treated with external beam radiation therapy alone (2006) (57)
Preoperative combined nested reverse transcriptase polymerase chain reaction for prostate-specific antigen and prostate-specific membrane antigen does not correlate with pathologic stage or biochemical failure in patients with localized prostate cancer undergoing radical prostatectomy. (2002) (57)
Optical tracking technology in stereotactic radiation therapy. (2007) (56)
Improvement in relapse-free survival throughout the PSA era in patients with localized prostate cancer treated with definitive radiotherapy: year of treatment an independent predictor of outcome. (2003) (54)
Brain metastases from bladder carcinoma: presentation, treatment and survival. (2002) (54)
Radiation dose response in patients with favorable localized prostate cancer (Stage T1-T2, biopsy Gleason < or = 6, and pretreatment prostate-specific antigen < or = 10). (2001) (54)
Pretreatment Immune Parameters Predict for Overall Survival and Toxicity in Early-Stage Non-Small-Cell Lung Cancer Patients Treated With Stereotactic Body Radiation Therapy. (2016) (51)
Expanding the use of real‐time electromagnetic tracking in radiation oncology (2011) (50)
Early prostate‐specific antigen (PSA) kinetics following prostate carcinoma radiotherapy (2004) (46)
Feasibility of extreme dose escalation for glioblastoma multiforme using 4π radiotherapy (2014) (46)
Performance evaluation of an improved optical computed tomography polymer gel dosimeter system for 3D dose verification of static and dynamic phantom deliveries. (2008) (45)
Positional stability of electromagnetic transponders used for prostate localization and continuous, real-time tracking. (2007) (45)
Failure definition-dependent differences in outcome following radiation for localized prostate cancer: can one size fit all? (2003) (44)
Age and PSA predict likelihood of organ-confined disease in men presenting with PSA less than 10 ng/mL: implications for screening. (2003) (44)
Pathologic stage migration has slowed in the late PSA era. (2007) (44)
Identification and fine mapping of a region showing a high frequency of allelic imbalance on chromosome 16q23.2 that corresponds to a prostate cancer susceptibility locus. (2000) (43)
Feasibility of prostate robotic radiation therapy on conventional C-arm linacs. (2014) (43)
Modeling Real-Time 3-D Lung Deformations for Medical Visualization (2008) (43)
A model for predicting lung cancer response to therapy. (2007) (42)
Dosimetric effect of prostate motion during helical tomotherapy. (2009) (39)
Factors affecting recurrence rates after prostatectomy or radiotherapy in localized prostate carcinoma patients with biopsy Gleason score 8 or above (2002) (39)
Localized prostate cancer: radiation or surgery? (2003) (38)
Long-Term (10-Year) Gastrointestinal and Genitourinary Toxicity after Treatment with External Beam Radiotherapy, Radical Prostatectomy, or Brachytherapy for Prostate Cancer (2012) (37)
Race as an independent predictor of outcome after treatment for localized prostate cancer. (1999) (37)
No difference in biochemical failure rates with or without pelvic lymph node dissection during radical prostatectomy in low-risk patients. (2000) (36)
Daily variations in the position of the prostate bed in patients with prostate cancer receiving postoperative external beam radiation therapy. (2006) (36)
Analysis of prognostic factors for patients with single brain metastasis treated with stereotactic radiosurgery. (1997) (35)
A treatment planning comparison between modulated tri-cobalt-60 teletherapy and linear accelerator-based stereotactic body radiotherapy for central early-stage non-small cell lung cancer. (2016) (35)
Incorporating cancer stem cells in radiation therapy treatment response modeling and the implication in glioblastoma multiforme treatment resistance. (2015) (33)
Radioresistance of the breast tumor is highly correlated to its level of cancer stem cell and its clinical implication for breast irradiation. (2014) (33)
Is year of radical prostatectomy a predictor of outcome in prostate cancer? (2004) (32)
Image-guided radiotherapy for prostate cancer (2018) (32)
Aggressiveness of familial prostate cancer. (2006) (31)
Head and Neck Non-Melanoma Skin Cancer Treated By Superficial X-Ray Therapy: An Analysis of 1021 Cases (2016) (31)
Feasibility of magnetic resonance imaging-guided liver stereotactic body radiation therapy: A comparison between modulated tri-cobalt-60 teletherapy and linear accelerator-based intensity modulated radiation therapy. (2015) (31)
Correlation between dosimetric effect and intrafraction motion during prostate treatments delivered with helical tomotherapy (2008) (31)
Nadir prostate-specific antigen within 12 months after radiotherapy predicts biochemical and distant failure. (2006) (30)
Investigation of accelerated partial breast patient alignment and treatment with helical tomotherapy unit. (2008) (30)
Multiparametric magnetic resonance imaging for prostate cancer improves Gleason score assessment in favorable risk prostate cancer. (2015) (29)
Evaluation of a diode array for QA measurements on a helical tomotherapy unit. (2005) (29)
Image-guided, adaptive radiotherapy of prostate cancer: toward new standards of radiotherapy practice. (2011) (28)
The dosimetric effect of intrafraction prostate motion on step-and-shoot intensity-modulated radiation therapy plans: magnitude, correlation with motion parameters, and comparison with helical tomotherapy plans. (2012) (28)
Redefining high-risk prostate cancer based on distant metastases and mortality after high-dose radiotherapy with androgen deprivation therapy. (2012) (27)
Resectable esophageal carcinoma: local control with neoadjuvant chemotherapy and radiation therapy. (1999) (27)
SBRT and HDR brachytherapy produce lower PSA nadirs and different PSA decay patterns than conventionally fractionated IMRT in patients with low- or intermediate-risk prostate cancer. (2016) (27)
Late rectal toxicity after low-dose-rate brachytherapy: incidence, predictors, and management of side effects. (2015) (26)
Local Failure and Survival After Definitive Radiotherapy for Aggressive Prostate Cancer: An Individual Patient-level Meta-analysis of Six Randomized Trials. (2019) (26)
Current concepts in F18 FDG PET/CT-based radiation therapy planning for lung cancer (2012) (26)
Image guidance during head-and-neck cancer radiation therapy: analysis of alignment trends with in-room cone-beam computed tomography scans. (2012) (25)
Dosimetric effects of rotational output variation and x-ray target degradation on helical tomotherapy plans. (2009) (24)
Content Validity of Anatomic Site-Specific Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE) Item Sets for Assessment of Acute Symptomatic Toxicities in Radiation Oncology. (2018) (24)
Increasing external beam dose for T1-T2 prostate cancer: effect on risk groups. (2006) (23)
Prostate Intrafraction Translation Margins for Real-Time Monitoring and Correction Strategies (2011) (23)
Real-time motion-adaptive-optimization (MAO) in TomoTherapy (2009) (23)
Focal high-dose-rate brachytherapy: a dosimetric comparison of hemigland vs. conventional whole-gland treatment. (2013) (23)
Dosimetric parameters predict short-term quality-of-life outcomes for patients receiving stereotactic body radiation therapy for prostate cancer. (2015) (22)
Comparison of transabdominal ultrasound and electromagnetic transponders for prostate localization (2007) (22)
Ten-Year Outcomes of Moderately Hypofractionated (70 Gy in 28 fractions) Intensity Modulated Radiation Therapy for Localized Prostate Cancer. (2019) (22)
Association of Gleason Grade With Androgen Deprivation Therapy Duration and Survival Outcomes: A Systematic Review and Patient-Level Meta-analysis (2019) (21)
Time-driven activity-based costing of low-dose-rate and high-dose-rate brachytherapy for low-risk prostate cancer. (2016) (21)
A phase I/II trial of gefitinib given concurrently with radiotherapy in patients with nonmetastatic prostate cancer. (2010) (21)
Exploring Value From the Patient's Perspective Between Modern Radiation Therapy Modalities for Localized Prostate Cancer. (2017) (21)
TH‐C‐BRC‐11: 3D Tracking of Interfraction and Intrafraction Head and Neck Anatomy during Radiotherapy Using Multiple Kinect Sensors (2011) (20)
Assessment of interfraction patient setup for head-and-neck cancer intensity modulated radiation therapy using multiple computed tomography-based image guidance. (2013) (20)
Brain Metastases from Gynecological Cancers: Factors that Affect Overall Survival (2002) (20)
Correlation of quantitative diffusion‐weighted and dynamic contrast‐enhanced MRI parameters with prognostic factors in prostate cancer (2014) (20)
Quantifying the Ki-67 Heterogeneity Profile in Prostate Cancer (2013) (20)
Does a family history of prostate cancer result in more aggressive disease? (1998) (19)
Location Matters: Stage I Non–Small‐cell Carcinomas of the Lower Lobes Treated With Stereotactic Body Radiation Therapy Are Associated With Poor Outcomes (2017) (19)
A mobile shield to reduce scatter radiation to the contralateral breast during radiotherapy for breast cancer: preclinical results. (1999) (19)
The Influence of Intrafraction Movement on Margins for Prostate Radiotherapy (2005) (19)
A multi-institutional analysis of adjuvant and salvage radiotherapy after radical prostatectomy (2004) (18)
Patient-reported quality of life after stereotactic body radiation therapy versus moderate hypofractionation for clinically localized prostate cancer. (2016) (18)
Clinical Assessment of Prostate Displacement and Planning Target Volume Margins for Stereotactic Body Radiotherapy of Prostate Cancer (2020) (18)
Association between a CYP 3 A 4 Genetic Variant and Clinical Presentation in African-American Prostate Cancer Patients 1 (2000) (18)
Evolving treatment plan quality criteria from institution-specific experience. (2012) (18)
An inverse hyper-spherical harmonics-based formulation for reconstructing 3D volumetric lung deformations (2010) (18)
Short-course, intensity-modulated radiotherapy for localized prostate cancer. (2001) (18)
Stereotactic body radiation therapy for abdominal and pelvic oligometastases: Dosimetric targets for safe and effective local control. (2015) (17)
Prostate-only Versus Whole-pelvis Radiation with or Without a Brachytherapy Boost for Gleason Grade Group 5 Prostate Cancer: A Retrospective Analysis. (2020) (17)
Accelerating dynamic magnetic resonance imaging (MRI) for lung tumor tracking based on low-rank decomposition in the spatial-temporal domain: a feasibility study based on simulation and preliminary prospective undersampled MRI. (2014) (17)
Helical tomotherapy: image-guided and adaptive radiotherapy. (2011) (17)
Enhancing Career Paths for Tomorrow's Radiation Oncologists. (2019) (16)
Causes of mortality after dose-escalated radiation therapy and androgen deprivation for high-risk prostate cancer. (2013) (16)
A GPU based high-resolution multilevel biomechanical head and neck model for validating deformable image registration. (2014) (16)
The significance of PTV dose coverage on cancer control outcomes in early stage non-small cell lung cancer patients treated with highly ablative stereotactic body radiation therapy. (2016) (16)
A Pooled Analysis of Biochemical Failure in Intermediate-risk Prostate Cancer Following Definitive Stereotactic Body Radiotherapy (SBRT) or High-Dose-Rate Brachytherapy (HDR-B) Monotherapy (2016) (16)
A nonvoxel-based dose convolution/superposition algorithm optimized for scalable GPU architectures. (2014) (16)
Multiparametric MRI identifies and stratifies prostate cancer lesions: implications for targeting intraprostatic targets. (2014) (16)
Abstract19: Dose-per-Fraction Escalation for Localized Prostate Cancer - A Multi-Institutional Phase I/II Trial (2006) (15)
Stereotactic Body Radiotherapy for High-Risk Localized CARcinoma of the Prostate (SHARP) Consortium: Analysis of 344 Prospectively Treated Patients. (2020) (15)
Re: Biological aggressiveness of hereditary prostate cancer: long-term evaluation following radical prostatectomy. (1999) (15)
Whole Versus Partial Bladder Radiation: Use of an Image-guided Hypofractionated IMRT Bladder-preservation Protocol (2015) (15)
A Phase I/II Trial of Dose-per-Fraction Escalation for Prostate Cancer (2007) (15)
Identifying the Best Candidates for Prostate-specific Membrane Antigen Positron Emission Tomography/Computed Tomography as the Primary Staging Approach Among Men with High-risk Prostate Cancer and Negative Conventional Imaging. (2021) (15)
Plan quality and dosimetric association of patient-reported rectal and urinary toxicities for prostate stereotactic body radiotherapy. (2016) (14)
Modeling Airflow Using Subject-Specific 4DCT-Based Deformable Volumetric Lung Models (2012) (14)
Dose-Response with Stereotactic Body Radiotherapy for Prostate Cancer: A Multi-Institutional Analysis of Prostate-Specific Antigen Kinetics and Biochemical Control. (2020) (14)
4D-CT Lung registration using anatomy-based multi-level multi-resolution optical flow analysis and thin-plate splines (2014) (14)
Multi-institutional Analysis of Prostate-Specific Antigen Kinetics Following Stereotactic Body Radiotherapy (SBRT). (2018) (13)
Clinical Outcomes for Patients With Gleason Score 10 Prostate Adenocarcinoma: Results From a Multi-institutional Consortium Study. (2017) (13)
Near Real-Time Assessment of Anatomic and Dosimetric Variations for Head and Neck Radiation Therapy via Graphics Processing Unit-based Dose Deformation Framework. (2015) (13)
Rates of biochemical remission remain higher in black men compared to white men after radical prostatectomy despite similar trends in prostate specific antigen induced stage migration. (2007) (13)
Year of treatment as independent predictor of relapse-free survival in patients with localized prostate cancer treated with definitive radiotherapy in the PSA era. (2004) (13)
Pattern of solid and hematopoietic second malignancy after local therapy for prostate cancer. (2017) (13)
Clinical Experience with the Calypso® 4D Localization System in Prostate Cancer Patients: Implantation, Tolerance, Migration, Localization and Real Time Tracking (2005) (13)
Prostate cancer: image guidance and adaptive therapy. (2007) (13)
Pretreatment Anemia Portends Poor Survival and Nonlocal Disease Progression in Patients with Stage I Non–Small Cell Lung Cancer Treated with Stereotactic Body Radiation Therapy (2016) (13)
Real-Time Simulation of 4D Lung Tumor Radiotherapy Using a Breathing Model (2008) (13)
Prostate-specific antigen kinetics and biochemical control following stereotactic body radiation therapy, high dose rate brachytherapy, and low dose rate brachytherapy: A multi-institutional analysis of 3,502 patients. (2020) (12)
Dosimetric feasibility of magnetic resonance imaging-guided tri-cobalt 60 preoperative intensity modulated radiation therapy for soft tissue sarcomas of the extremity. (2015) (12)
SU‐GG‐T‐286: Performance of An Improved Optical Computed Tomography Polymer Gel Dosimeter System for 3‐D Dose Verification of Static and Dynamic Phantom Deliveries (2008) (12)
Characterization and use of EBT radiochromic film for IMRT dose verification. (2006) (12)
Positional and Volumetric Changes in Parotid Glands During Head and Neck Radiation Therapy Assessed Using Deformable Image Registration (2007) (11)
Impact of the Primary Information Source Used for Decision Making on Treatment Perceptions and Regret in Prostate Cancer (2017) (11)
Time and PSA threshold model prognosticates long-term overall and disease-specific survival in prostate cancer patients as early as 3 months after external beam radiation therapy (2005) (11)
Intermediate‐Term Outcome with Radical Prostatectomy for Localized Prostate Cancer: The Cleveland Clinic Experience (2001) (11)
The Intraprostatic Immune Environment after Stereotactic Body Radiotherapy is Dominated by Myeloid Cells (2020) (11)
Locally advanced prostate cancer (2001) (11)
The biochemical and clinical significance of the post-treatment PSA bounce for prostate cancer patients treated with external beam radiation therapy alone: A multi-institutional pooled analysis (2004) (11)
Pro-inflammatory State Portends Poor Outcomes with Stereotactic Radiosurgery for Brain Metastases. (2016) (11)
A GPU-based framework for modeling real-time 3D lung tumor conformal dosimetry with subject-specific lung tumor motion (2010) (11)
A comparison of soft-tissue implanted markers and bony anatomy alignments for image-guided treatments of head-and-neck cancers. (2010) (10)
Extent of extracapsular extension: Implications for planning for conformal radiotherapy and brachytherapy (1998) (10)
Thoracic CT-PET Registration Using a 3D Breathing Model (2007) (10)
Clinical Indicators of Psychosocial Distress Predict for Acute Radiation-Induced Fatigue in Patients Receiving Adjuvant Radiation Therapy for Breast Cancer: An Analysis of Patient-Reported Outcomes. (2016) (10)
Daily transabdominal ultrasound localization of the prostate gland with the BAT system: 2705 alignments from 100 patients (2000) (10)
Image-Guided Positioning and Tracking (2011) (10)
Treatment planning comparison of volumetric modulated arc therapy employing a dual-layer stacked multi-leaf collimator and helical tomotherapy for cervix uteri (2020) (10)
Stereotactic body radiation therapy for prostate cancer: Rational and reasonable. (2015) (10)
Performance of a Prostate-Specific Membrane Antigen Positron Emission Tomography/Computed Tomography–Derived Risk-Stratification Tool for High-risk and Very High-risk Prostate Cancer (2021) (10)
A Phase I/II Trial of Increasingly Hypofractionated Radiation Therapy for Prostate Cancer (2009) (10)
Perils of comparing toxicities between stereotactic body radiation and intensity-modulated radiation therapy for prostate cancer on the basis of incomplete demographic registries. (2014) (10)
1022 Is whole brain radiation therapy needed for all patients with newly diagnosed brain metastases undergoing stereotactic radiosurgery (1997) (9)
Tomotherapy improves local control and changes failure patterns in locally advanced malignant pleural mesothelioma. (2015) (9)
Modeling simulation and visualization of conformal 3D lung tumor dosimetry (2009) (9)
4Pi Radiation therapy for Liver SBRT (2012) (9)
Interplay Between Duration of Androgen Deprivation Therapy and External Beam Radiotherapy With or Without a Brachytherapy Boost for Optimal Treatment of High-risk Prostate Cancer (2022) (9)
Selective Radioprotection of Normal Tissues with Cerium Oxide Nanoparticles (2008) (9)
Real Time Prostate Translation, Rotation, Deformation Evaluated with Calypso Beacon™ Transponders (2005) (9)
A Display Framework for Visualizing Real-Time 3D Lung Tumor Radiotherapy (2008) (9)
IMPROVEMENT IN OVERALL SURVIVAL FOR PATIENTS WITH LOCALIZED PROSTATE CANCER WITH HIGHER THAN STANDARD RADIATION DOSES: PRELIMINARY RESULTS (1999) (8)
Visualization of tumor-influenced 3D lung dynamics (2006) (8)
Cost-effectiveness of Linac-based single-isocenter non-coplanar technique (HyperArcTM) for brain metastases radiosurgery (2018) (8)
A Multi-Institutional Phase I/II Trial of Dose-per-fraction Escalation for Localized Prostate Cancer (2005) (8)
A multi-GPU real-time dose simulation software framework for lung radiotherapy (2012) (8)
Effect of prostate-specific antigen screening on metastatic disease burden 10 years after diagnosis. (2012) (8)
Validation of a computational method for assessing the impact of intra-fraction motion on helical tomotherapy plans (2009) (8)
Adjuvant versus neoadjuvant androgen deprivation with radiotherapy for prostate cancer: does sequencing matter? (2015) (7)
Using daily MVCT images to calculate daily rectal dose volume histograms in prostate cancer patients treated with a helical tomotherapy unit (2004) (7)
Monotherapy for stage T1/T2 prostate cancer: radical prostatectomy, external beam radiotherapy, or permanent prostate brachytherapy (2002) (7)
Four-Dimensional Computed Tomography Lung Registration Methods (2011) (7)
Implant experience and positional stability of AC magnetic beacon™ transponders used to localize patients for external beam radiation therapy of the prostate (2004) (7)
Quality of life outcomes from a dose-per-fraction escalation trial of hypofractionation in prostate cancer. (2016) (7)
Correlation of Quantitative Diffusion-Weighted and Dynamic Contrast-Enhanced MRI Parameters With NCCN Risk Group, Gleason Score, and Maximum Tumor Diameter in Prostate Cancer. (2013) (7)
Five-year Efficacy and Toxicity Outcomes from a Phase I/II Trial of Increasingly Hypofractionated Radiation Therapy for Prostate Cancer (2011) (6)
Patterns of Clinical Progression in Radiorecurrent High-risk Prostate Cancer. (2021) (6)
Patient-Reported Quality of Life After Stereotactic Body Radiation Therapy Versus Moderate Hypofractionation for Clinically Localized Prostate Cancer (2016) (6)
Long-term outcomes of stereotactic body radiotherapy for low- and intermediate-risk prostate adenocarcinoma: A multi-institutional consortium study. (2018) (6)
Does the addition of targeted prostate biopsies to standard systemic biopsies influence treatment management for radiation oncologists? (2016) (6)
Year of treatment is an independent predictor of outcome in patients with localized prostate cancer treated with definitive radiotherapy (2001) (6)
A client–server framework for 3D remote visualization of radiotherapy treatment space (2013) (6)
The American Board of Radiology Focused Practice Recognition in Brachytherapy (FPRB) Program: Opportunities lost, lessons learned, and future implications. (2015) (6)
Fast simulated annealing and adaptive Monte Carlo sampling based parameter optimization for dense optical-flow deformable image registration of 4DCT lung anatomy (2016) (6)
Toxicity after hypofractionated external beam radiotherapy (70 GY at 2.5 GY per fraction) versus standard fractionation radiotherapy (78 GY at 2.0 GY per fraction) for localized prostate cancer (2002) (6)
Gantry-Mounted Linear Accelerator–Based Stereotactic Body Radiation Therapy for Low- and Intermediate-Risk Prostate Cancer (2019) (5)
Patient-specific Dose From Megavoltage CT Imaging With a Helical Tomotherapy Unit (2007) (5)
Race is not an independent factor affecting outcome after radical prostatectomy or definitive radiotherapy for localized adenocarcinoma of the prostate (1998) (5)
Comparison of Multimodal Therapies and Outcomes Among Patients With High-Risk Prostate Cancer With Adverse Clinicopathologic Features (2021) (5)
Stereotactic Body Radiotherapy for High-Risk Prostate Cancer: Preliminary Toxicity Results of a Phase 2 Trial (2017) (5)
Phase I Trial of Stereotactic Body Radiotherapy Neoadjuvant to Radical Prostatectomy for Patients with High-Risk Prostate Cancer. (2020) (5)
Underutilization of Androgen Deprivation Therapy with External Beam Radiotherapy in Men with High-grade Prostate Cancer. (2019) (5)
Clinical Outcomes of High-Dose-Rate Interstitial Gynecologic Brachytherapy for Primary Locally Advanced Cervical Cancer (2014) (5)
Biocompatibility of a wireless electromagnetic transponder permanent implant for accurate localization and continuous tracking of tumor targets (2003) (5)
1192: A Nomogram to Predict the Outcome of Salvage Radiotherapy (RT) for Biochemical Recurrence (BCR) Following Radical Prostatectomy (RP) (2006) (5)
Shielding implications for secondary neutrons and photons produced within the patient during IMPT. (2013) (5)
SU-FF-T-363: Dynamic Tangents and Topotherapy: New Delivery Capabilities for Helical Tomotherapy (2005) (5)
In Regard to Bauman et al. (2015) (5)
Testosterone Levels and Sexual Quality of Life After Stereotactic Body Radiation Therapy for Prostate Cancer: A Multi-Institutional Analysis of Prospective Trials. (2017) (5)
Dosimetric benefits of hemigland stereotactic body radiotherapy for prostate cancer: implications for focal therapy. (2015) (4)
ANDROGEN DEPRIVATION IN COMBINATION WITH SURGERY OR RADIOTHERAPY FOR LOCALIZED PROSTATE CANCER: WHEN IS IT USEFUL? (1999) (4)
Radiotherapy: Effect of treatment interruptions in prostate cancer (2009) (4)
Results of Patients with Newly Diagnosed Single Brain Metastasis Treated with Stereotactic Radiosurgery with or without Whole Brain Radiation Therapy (1997) (4)
External beam radiation therapy: role of androgen deprivation (2003) (4)
SU‐GG‐T‐270: Evaluation of a Novel 3‐D Polymer Gel Dosimetry System for Proton Radiotherapy (2008) (4)
Evaluation of Breast Tumor Bed Alignment Techniques for Image Guided Radiotherapy (2005) (4)
Association between Long-Term Second Malignancy Risk and Radiation: A Comprehensive Analysis of the Entire Surveillance, Epidemiology, and End Results Database (1973-2014) (2019) (4)
Short course intensity modulated radiotherapy (70 Gy at 2.5 Gy per fraction) versus 3D-conformal radiotherapy (78 Gy at 2.0 Gy per fraction) for the treatment of localized prostate cancer: comparable toxicity (2000) (4)
SU-D-201-05: On the Automatic Recognition of Patient Safety Hazards in a Radiotherapy Setup Using a Novel 3D Camera System and a Deep Learning Framework. (2016) (4)
A phase I/II trial of gefitinib given concurrently with radiotherapy in patients with nonmetastatic prostate cancer. (2009) (4)
Stereotactic body radiotherapy for high-risk prostate cancer (5 treatment days): Toxicity results of a phase II trial. (2017) (4)
Does Image Guidance Need to be Performed Daily in the Treatment of Localized Prostate Cancers? Implications on Treatment Margins (2007) (4)
In response to Dr. Dar et al (2006) (4)
Dependence of achievable plan quality on treatment technique and planning goal refinement: a head-and-neck intensity modulated radiation therapy application. (2015) (4)
SU-F-T-102: Automatic Curation for a Scalable Registry Using Machine Learning. (2016) (4)
4π Non-Coplanar SBRT for Centrally Located or Larger Lung Tumors (2013) (4)
Contribution 4 p Noncoplanar Stereotactic Body Radiation Therapy for Head-and-Neck Cancer : Potential to Improve Tumor Control and Late Toxicity (2014) (3)
A Comparison of Long-Term Treatment-Related Toxicities Between Moderately Hypofractionated and Conventionally Fractionated Radiation Therapy for Localized Prostate Cancer (2014) (3)
Are Pre and Post Imaging Sufficient to Assess Intrafraction Prostate Motion (2007) (3)
Predicting outcome after PSA failure in prostate cancer patients treated by radiation. Who needs salvage therapy (2004) (3)
Clinical outcomes and prognostic factors in 4839 patients treated with external radiotherapy for stage T1-T2 prostate cancer (2004) (3)
Hypofractionation and prostate cancer: A good option for Africa? (2017) (3)
Accuracy of a 4D magnetic localization system: Evaluation in the clinical environment (2004) (3)
Megavoltage Computed Tomography Image-based Low-dose Rate Intracavitary Brachytherapy Planning for Cervical Carcinoma (2009) (3)
Predictors of High-Grade Rectal Toxicity Observed in a Phase 1/2 Trial of Stereotactic Body Radiation Therapy for Prostate Cancer (2013) (3)
Development of a Radiation Oncology-Specific Prospective Data Registry for Research and Quality Improvement: A Clinical Workflow-Based Solution. (2018) (3)
Radiotherapy versus radical prostatectomy for Gleason score 9-10 prostate adenocarcinoma: A multi-institutional comparative analysis of 1001 patients treated in the modern era. (2017) (3)
Image Guided Radiotherapy Plan Evaluation based on Deformable Dose Registration from Daily On-line Positioning Images (2005) (3)
TH-AB-204-04: On the Feasibility of a Multi-3D Kinect V2 Camera System for Monitoring Radiation Therapy Treatment Setup and Improving Patient Safety (2015) (3)
Contribution 4 p Noncoplanar Stereotactic Body Radiation Therapy for Centrally Located or Larger Lung Tumors (2013) (3)
First Prospective Trial in Linear Accelerator–Based 4π Radiation Therapy: Initial Results in Patients With Recurrent Glioblastoma (2016) (3)
Adjuvant versus neoadjuvant androgen deprivation with radiation therapy for prostate cancer: Does sequencing matter? (2013) (3)
WE-D-I-6B-09: Tracking Prostate Motion and Isocenter Offset During Treatment Using the Calypos(tm) 4D Localization System (2005) (3)
TU‐FF‐A2‐06: The Use of MVCT Images for Dose Calculation in the Presence of Metallic Objects (2005) (3)
RapidPlan hippocampal sparing whole brain model version 2-how far can we reduce the dose? (2022) (3)
Localized prostate cancer treated with radiotherapy: who benefits from hormonal therapy? (2000) (3)
Visualization of 3D Volumetric Lung Dynamics for Real-Time External Beam Lung Radiotherapy (2011) (2)
Collaborative Engineering: 3-D Optical Imaging and Gas Exchange Simulation of In-Vitro Alveolar Constructs (2008) (2)
COMMENT ON : BIOLOGICAL AGGRESSIVENESS OF HEREDITARY PROSTATE CANCER : LONG-TERM EVALUATION FOLLOWING RADICAL PROSTATECTOMY. AUTHORS' REPLY (1999) (2)
140 Factors associated with biochemical relapse after either low-dose external beam radiation, high-dose external beam radiation, or radical prostatectomy for localized prostate cancer: 8 year results (1999) (2)
Multi-Scale, Multi-Modal Image Integration for Image-Guided Clinical Interventions in the Head and Neck Anatomy (2013) (2)
1017 : Position Correction Guidance Utilizing Real-Time Tracking With the Calypso® System for External Radiation Therapy Delivery in Patients With Localized Prostate Cancer (2006) (2)
A comparison of overall and cause-specific survival among patients with low- and intermediate-risk prostate cancer treated with brachytherapy, external beam radiotherapy, or radical prostatectomy (2007) (2)
Three-dimensional Feature Recognition-based Automated Patient Treatment Mismatch Verification System for Radiation Therapy (2012) (2)
2266: Stability of Intraprostatic Electromagnetic Transponders in Patients Receiving Radiation Therapy, With and Without Neoadjuvant and/or Concurrent Androgen Suppression Therapy (2006) (2)
Impact of high-dose radiation on Erectile Function in patients treated with intensity-modulated radiation therapy for prostate cancer (2004) (2)
Overall survival after development of metastatic disease following local therapy in patients treated for localized prostate cancer in the PSA era (2003) (2)
2290 : Efficiency of a Non-Ionzing Target Localization System for Radiation Therapy (2006) (2)
Adapting the PRO-CTCAE for Patient Reporting of Toxicity in Radiation Oncology (2012) (2)
Localized prostate cancer (2000) (2)
Clinical use of Electromagnetic Guidance for Lung and Spine Radiation Therapy (2008) (2)
Conformal External Beam Radiation Therapy (2004) (2)
TU‐D‐BRB‐09: Dosimetric Validation of the Proton‐Sensitive BANG® 3 PRO‐2 Polymer Gel Dosimeter Irradiated by Single Field Therapeutic Proton Beams (2009) (2)
Considerations for Quality Improvement in Radiation Oncology Therapy for Patients with Uncomplicated Painful Bone Metastases. (2017) (2)
Multi-Kinect v2 Camera Based Monitoring System for Radiotherapy Patient Safety (2016) (2)
Prostate Margins for Real-Time Monitoring and Correction Strategies (2007) (2)
Concomitant Boost of the Peripheral Zone with Hypofractionated Radiotherapy in Locally Advanced Pros (2009) (2)
2371 : Clinical Application of Deformable Image Registration in Head and Neck Cancer Radiotherapy: Does Planned Dose to Tumor and Normal Structures Change During Treatment? (2006) (2)
180 : Deformable Image Registration and Replanning in Head And Neck Radiotherapy for Optimization of Parotid Sparing (2006) (2)
Intra-fraction Prostate Motion: Dosimetric Impact on Delivered Doses (2007) (2)
681: Blacks Continue To Lag Caucasians in Cure Rates after Radical Prostatectomy Late in the PSA Era Despite PSA-Induced Clinical Stage Migration (2006) (2)
1014 Factors influencing local control and survival for patients undergoing stereotactic radiosurgery for intracranial metastases (1996) (2)
Daily megavoltage CT image guidance in the treatment of localized prostate cancer (2004) (2)
SU‐FF‐J‐85: Automatic Seed Detection in MVCT Images for Prostate Radiotherapy (2005) (2)
Dosimetric Consequences of Intrafraction Prostate Motion on Patients Enrolled on Multi-Institutional Hypofractionation Study (2007) (2)
Ultrasound Versus Seed Marker Prostate Localization (2005) (2)
Feasibility of extreme dose escalation for glioblastoma multiforme using 4π radiotherapy (2014) (1)
TU‐G‐BRA‐05: Intra‐Fraction Motion Management for Prostate SBRT: Clinical Experience and Imaging Frequency Analysis (2012) (1)
The Influence of an Endorectal Balloon on Intrafraction Prostate Motion (2010) (1)
Mortality in Men Treated With Radiation Therapy and Androgen Deprivation for High-risk Prostate Cancer in the Modern Era is Driven by Non-prostate Cancer Deaths (2012) (1)
2047 : Partial Breast Irradiation With Helical Tomotherapy Using RTOG 0413 Planning Constraints (2006) (1)
Abstract2236: Prostate Rotation Measured by Electromagnetic Tracking System: A Multi-Center Analysis (2006) (1)
Patient-Reported Outcome After Prostate Stereotactic Body Radiation Therapy—An Analysis of Dosimetric Correlation of Minimally Import Difference for the Expanded Prostate Cancer Index Composite Short Form (EIPIC-26) (2016) (1)
Long-term (potential 10-year follow-up) toxicity after treatment for prostate cancer with either external beam radiation therapy, interstitial brachytherapy, or radical prostatectomy. (2011) (1)
Radiation dose response in patients with favorable localized prostate cancers (stage T1–T2, biopsy gleason ≤6, and pretreatment PSA ≤ 10) (2000) (1)
Evaluating Intrafraction Motion of the Prostate in the Prone and Supine Positions using Electromagnetic Tracking (2009) (1)
Racial Disparity in Androgen Deprivation Therapy Utilization for Men with High-Risk Prostate Cancer Treated with Intensity-Modulated Radiation Therapy in the Modern Era – A SEER-Medicare Linked Database Analysis (2018) (1)
LINICAL INVESTIGATION Head and Neck EVALUATION OF IMAGE-GUIDANCE PROTOCOLS IN THE TREATMENT OF HEAD AND NECK CANCERS (2007) (1)
High-Risk Prostate Cancer: Radiation or Surgery? (2013) (1)
SU‐E‐J‐156: A 3D Camera Test‐Bed for Real‐Time Monitoring and Quantitative Tracking of Radiotherapy Treatment (2013) (1)
SU‐FF‐T‐06: Megavoltage CT Imaging Enables CT‐Based Low‐Doserate Brachytherapy Planning Without CT‐Compatible Applicators (2005) (1)
SU-E-J-73: Effect of 4D-CT Image Artifacts On the 3D Lung Registration Accuracy: A Parametric Study Using a GPU-Accelerated Multi-Resolution Multi-Level Optical Flow. (2013) (1)
Prognostic risk group stratification for clinical and biochemical failure after external beam radiation of localized prostate cancer (2004) (1)
Abstract 1403: Harnessing nanoparticles to improve toxicity after head and neck radiation (2010) (1)
Promises and Pitfalls: Development of the National Brachytherapy Registry. (2015) (1)
2218 : Relapse-Free Survival With Escalating External Beam Radiation Doses in the Treatment of Localized Prostate Cancer: 74 Gy at 2 Gy, 78 Gy at 2 Gy, and Hypofractionated 70 Gy at 2.5 Gy per Fraction (2006) (1)
Focal Therapy and the Index Lesion Hypothesis in Prostate Cancer (2013) (1)
Daily megavoltage ct imaging for lung cancer during a course of external beam radiotherapy with a helical tomotherapy device (2004) (1)
Original article Continuing trends in pathological stage migration in radical prostatectomy specimens (2004) (1)
1230 poster AN ENDORECTAL BALLOON REDUCES INTRAFRACTION PROSTATE MOTION DURING RADIOTHERAPY (2011) (1)
Prostate Cancer Radiation Therapy (2000) (1)
Location, Location, Location: Lower Lobe Stage I Non-Small Cell Lung Cancer Treated With Stereotactic Body Radiation Therapy Are Associated With Poor Outcomes (2016) (1)
Development of a nomogram to predict for all-cause and cancer-specific mortality in high-risk prostate cancer treated by external beam radiotherapy and androgen deprivation. (2013) (1)
Practical 4π Liver SBRT Using Eclipse Planning (2015) (1)
Head and Neck Nonmelanoma Skin Cancer Treated by Orthovoltage Radiation: An Analysis of 1021 Cases (2014) (1)
Use of Daily Megavoltage CT Imaging to Determine Delivered Dose Variations in Head and Neck Cancer Patients (2005) (1)
Implementation of a Comprehensive Radiation Therapy Registry: Focus on Feasibility and Reliability (2012) (1)
SU-C-BRE-03: Dual Compartment Mathematical Modeling of Glioblastoma Multiforme (GBM). (2014) (1)
SU‐DD‐A3‐03: Evaluation of An Infrared Camera and X‐Ray System for Gated Radiation Therapy (2005) (1)
Plan Quality Inference and Cross Validation for Standardization and Consistency Evaluation (2012) (1)
Definitions of biochemical failure that best predict clinical failure in prostate cancer patients treated with external beam radiation alone- a multi-institutional pooled analysis (2003) (1)
External Beam Radiation Dose Response and Toxicity in Low-Risk Prostate Cancer (2005) (1)
1136 : Characterization of Real Time Motion of the Prostate Gland in Patients Receiving External Radiotherapy for Localization Prostate Cancer: Tracking During 1157 Fractions With the Calypso System (2006) (1)
Use of Electromagnetic Technology for Four-Dimensional Radiotherapy Localisation and Realtime Tumour Tracking (2005) (1)
1011 Preoperative and pathologic prognostic factors affecting psa levels after radical prostatectomy alone in men with clinically localized prostate cancer (1995) (1)
WE‐E‐M100F‐04: Commissioning and Validation of a Beam Model for Calculating Megavoltage CT Dose From Imaging with a Helical Tomotherapy Unit (2007) (1)
Development of a radiation oncology-specific prospective data registry for clinical research and quality improvement: A clinical workflow-based solution. (2016) (1)
2795 : Use of Daily CT-Based Deformable Registration To Track Lung Daily Tumor Volumes and Position (2006) (1)
Prostate-Specific Antigen Kinetics Following Various Radiotherapy Modalities: A Multi-Institutional Analysis (2019) (1)
2275 : Clinical Impact of a 3 mm versus 5 mm Action Threshold for Correction of Intrafractional Prostate Motion Identified With Electromagnetic Tracking (2006) (1)
Gated Radiotherapy for Lung Tumors Using Infrared Detectors, Stereoscopic X-rays, and Implanted Markers (2005) (1)
TU‐G‐BRA‐05: Intra‐Fraction Motion Management for Prostate SBRT: Clinical Experience and Imaging Frequency Analysis (2012) (1)
Analytical modeling and feasibility study of a multi-GPU cloud-based server (MGCS) framework for non-voxel-based dose calculations (2017) (1)
TH‐D‐BRB‐06: Assessment of Proton Beam In‐Vivo Dose Verification by Directly Comparing Doses Measured in Tissue‐Equivalent Polymer Gels to Proton‐Activated Positron‐Emission Distributions in the Gels Post Irradiation (2009) (1)
Development and Validation of a Comprehensive Multivariate Dosimetric Model for Predicting Late Genitourinary Toxicity Following Prostate Cancer Stereotactic Body Radiotherapy (2020) (1)
Impact of the extent of extracapsular extension on outcome in patients undergoing radical prostatectomy (2001) (1)
Feasibility of Margin Reduction for Level II and III Planning Target Volume in Head-and-Neck Image-Guided Radiotherapy – Dosimetric Assessment via A Deformable Image Registration Framework (2015) (1)
Pretreatment Anemia Portends Poor Outcomes in Stage I Non-Small Cell Lung Cancer Patients Treated With Stereotactic Body Radiation Therapy (2016) (1)
DECREASING EXTRACAPSULAR EXTENSION RATES IN RADICAL PROSTATECTOMY: EVIDENCE FOR CONTINUED STAGE MIGRATION (1999) (1)
Counseling Patients With Localized Prostate Cancer (2004) (1)
Revisiting early PSA kinetics: did we omit their value prematurely? (2003) (1)
75 Stage T1–2 prostate cancer with pretreatment PSA 10 ng/ml or less: Radiotherapy or surgery? (1996) (1)
Salvage prostate fossa radiotherapy alone for biochemical failure after radical prostatectomy (2003) (1)
Hypofractionated Intensity Modulated Radiation Therapy for Localized Prostate Cancer: Long-term Outcomes and a Comparison to Standard Dose-Escalated RT (2013) (1)
Ultrasound for Patient Positioning in Radiation Therapy (2000) (1)
SU-E-I-58: Detecting Tumors with Extremely Low Contrast in CT Images. (2014) (1)
Analysis of Outcomes in Early-Stage Non-small Cell Lung Cancer Irradiation: Fractionation Scheme Implications for Stage I Versus Stage II Disease (2012) (1)
Megavoltage Computed Tomography Imaging (2008) (1)
4Pi Therapy for Partial Breast Irradiation (2012) (1)
Radiation of Potential Local Cancer Stem Cell Niches Improves Survival of Patients With Glioblastoma Multiforme (2012) (1)
Real-time Position Adjustment during Treatment for Localized Prostate Cancers: Observations on Clinical Use and Acute Toxicity (2009) (1)
Impact of the primary information source used for decision making and implications for treatment regret in prostate cancer. (2017) (1)
Cost-effectiveness of Linac-based single-isocenter non-coplanar technique (HyperArcTM) for brain metastases radiosurgery (2018) (0)
Clinical Assessment of the Planning Target Volume Margins for Stereotactic Body Radiotherapy of Prostate Cancer (2019) (0)
Interfraction Patient Setup for Multiple Volumetric-based Image Guidance Systems for Head and Neck IMRT (2012) (0)
Current in F18 FDG PET/CT-based radiation therapy planning for lung cancer. (2012) (0)
Localized prostate cancer. (2000) (0)
668: Cause-Specific Mortality after Radical Prostatectomy or External-Beam Radiation Therapy for Localized Prostate Cancer in the PSA Era: Results of a Single-Institution Nonrandomized Comparison (2005) (0)
An Ocular Photometric Method for Radiation Biodosimetry in Patients Following Whole Body Irradiation (2013) (0)
Image-guided Stereotactic Radiotherapy for Peripheral Lung Tumors: Gating vs. Motion Encompassing Approaches (2009) (0)
Quality of life assessment 3 year after hypofractionated external beam radiotherapy (70 GY at 2.5 GY per fraction) for localized prostate cancer: comparison with 3D conformal radiotherapy, and permanent seed implantation (2002) (0)
Real-Time Assessment of Dosimetric Variations in Head-and-Neck Radiation Therapy (2013) (0)
Results of definitive surgery and radiation therapy in elderly patients with supratentorial glioblastoma multiforme (1998) (0)
TH‐E‐BRCD‐04: Impact of Automatic Planning from Clinician's Perspective (2012) (0)
A Framework for Modeling and Visualizing Cardiovascular Deformation Under Normal and Altered Circulatory Conditions (2014) (0)
TU-D-BRA-02: Real-Time Guidance in Radiation Therapy: Present and Future Perspectives (2010) (0)
A novel external beam radiotherapy method for cervical cancer patients using virtual straight or bending boost areas; an in-silico feasibility study (2021) (0)
Androgen Deprivation and Radiation Therapy for Localized Prostate Cancer (2004) (0)
Nonrandomized single institutional comparison of radical prostatectomy, external beam radiotherapy, or permanent seed implantation in the management of localized prostate cancer. (2004) (0)
13. Are Pretreatment PSA Levels Predictive of Overall Survival after Prostatectomy or Radiotherapy for Localized Prostate Cancer (2003) (0)
Importance of clinical T stage in early-stage prostate cancer (2003) (0)
The impact of screening for prostate cancer on the development of metastatic disease. (2010) (0)
Impact of Real-time Prostate Motion on the Accuracy of Static Image Guidance Techniques (2007) (0)
A Comparison of Biochemical Relapse Free Survival (bRFS) Between Primary Gleason 3 and Primary Gleason 4 for Biopsy Gleason 7 Prostate Cancer (2007) (0)
Megavoltage CT Image-based Intracavitary Low Dose Rate Brachytherapy for Cervical Carcinoma (2005) (0)
Realtime Method to Locate and Track Targets in Radiotherapy (2006) (0)
SBRT and HDR Brachytherapy Produce Lower PSA Nadirs and More Rapid PSA Decline Than Conventionally Fractionated IMRT in Patients With Low- or Intermediate-Risk Prostate Cancer (2015) (0)
SU-FF-T-254: Helical Tomotherapy Radiosurgery Planning (2006) (0)
WE-G-108-04: Establishing a Quantitative Relation Between the Spectrum-Sampling Rate On the Dose Distribution Accuracy Using a GPU Based Convolution/superposition Algorithm. (2013) (0)
Tomotherapy Improves Local Control and Changes Failure Patterns in Locally Advanced Malignant Pleural Mesothelioma (2015) (0)
Reply to the Letter Regarding Kupelian et al. (2008) (0)
Quality of life assessment at 2 year post therapy in patients with prostate cancer treated with permanent seed implants, 3d conformal radiotherapy, or short course intensity modulated radiotherapy (2001) (0)
Institutional Adoption of a Standardized Brain Tumor Imaging Protocol Speeds Time From Consult to Stereotactic Radiosurgery for Brain Metastases. (2016) (0)
RAdiotherapy for Prostate cancer using HYpofractionation Directed by UltraSound (RAPHYDUS): a Brazilian public health care system study. (2022) (0)
SU-D-WAB-07: Documenting Dose Delivery for Head & Neck Radiotherapy Using a GPU Based Framework. (2013) (0)
The prognostic significance of PSA at 6 months after external beam radiation for prostate cancer (2004) (0)
Intrafraction Motion Management for Prostate SBRT: Clinical Experience and Motion Analysis (2012) (0)
Model guided multi-modal multi-scale image integration for head and neck anatomy (2012) (0)
Accelerated Hypofractionated CRT Followed by SABR Boost (HyCRT-SABR) for Locally Advanced Unresectable NSCLC: A Prospective Phase II Radiation Dose-Escalation Study (2019) (0)
MO-D-217BCD-01: Personalizing Medicine: Adapting to the Individual. (2012) (0)
Global response to radiation in prostate adenocarcinoma: examination of 12,000 genes and 48,000 ESTs following fractionated versus bolus radiation (2001) (0)
SU-FF-T-324: The Use of Megavoltage CT (MVCT) Images for Dose Recomputation (2005) (0)
Detecting Prostate Focal Lesions in CT Images (2014) (0)
MO-G-137-06: Evaluating Head-And-Neck 4pi Non-Coplanar Plans From the Perspective of Proton Therapy. (2013) (0)
Multi-institutional analysis of high-risk prostate cancer patients treated with stereotactic body radiotherapy. (2019) (0)
WE-E-BRE-10: Level of Breast Cancer Stem Cell Correlated with Tumor Radioresistence: An Indication for Individualized Breast Cancer Therapy Adapted to Cancer Stem Cell Fractions. (2014) (0)
A comparison of overall survival between patients with low- and intermediate-risk prostate cancer treated with brachytherapy, external beam radiotherapy, or radical prostatectomy (2007) (0)
Radiation Therapy Registries: An Example of Workflow and Data Architecture (2011) (0)
Use of the Electronic Medical Record to Facilitate Intervention for Patients With Rising Prostate-Specific Antigen Values After Radical Prostatectomy: A Feasibility Study. (2017) (0)
2213 : Tolerance, Stability and Reliability of Implanted Electromagnetic Transponders in the Prostate: A Multi-Center Analysis (2006) (0)
Do Anatomic Changes During Radiation Impact Normal Tissue and Target Dosimetry? An Analysis of Calculated Cumulative Dose in Head and Neck Patients (2007) (0)
Development of an Instrument for Acute Toxicity Assessment in Patients Receiving Breast Radiation Therapy (2016) (0)
A novel external beam radiotherapy method for cervical cancer patients using virtual straight or bending boost areas; an in-silico feasibility study (2021) (0)
No Impact of Rectal Distention at the Time of Planning on Control Rates in Prostate Cancer Patients Treated With Image Guided Radiotherapy (2007) (0)
7449 Accelerated lung MRI using Low-Rank Decomposition : a prospective and simulation study (2013) (0)
THE DOSIMETRIC CONSEQUENCE OF INTRA-FRACTION PROSTATE MOTION FOR TWO IMRT DELIVERY TECHNIQUES (2009) (0)
Correlation Between Point Doses and Volumetric Dose Parameters for CT-Based HDR Planning Using Fletcher-Suit-Delclos (FSD) Applicators (2014) (0)
Real-time simulation framework for lung tumor radiation therapy (2007) (0)
Time-and-psa threshold model predicts overall and disease-free survival after external beam therapy for prostate cancer (2004) (0)
SU-E-J-98: 3D Tracking of Interfraction Patient Setup Uncertainties Using Multiple Kinect Sensors. (2012) (0)
Identification of an Unfavorable Subgroup of High-risk, Localized Prostate Cancer Treated with External Beam Radiation (2010) (0)
Prospective radiotherapy for patients with oropharyngeal carcinoma - Authors' reply. (2017) (0)
LONG TERM RESULTS WITH RADIATION THERAPY IN THE PSA ERA; HOST AND TREATMENT FACTORS PREDICTING BIOCHEMICAL FAILURES (1999) (0)
SU-D-BRB-06: Treating Glioblastoma Multiforme (GBM) as a Chronic Disease: Implication of Temporal-Spatial Dose Fractionation Optimization Including Cancer Stem Cell Dynamics (2015) (0)
A Systematic Assessment of Head and Neck Deformable Image Registration Using High Resolution Biomechanical Models (2014) (0)
1022 : Evaluation of Image-Guidance Strategies in the Treatment of Head and Neck Cancers (2006) (0)
Irradiation of dominant intraprostatic lesions with short-course intensity modulated radiotherapy: Dosimetry and planning☆ (2000) (0)
Phase 2 Trial of Induction Chemotherapy Followed by Attenuated Chemoradiation Therapy for Human Papillomavirus–Positive Locally Advanced Squamous Cell Carcinoma of the Oropharynx (2016) (0)
SU-F-J-181: An Alternative Patient Alignment Tool On TomoTherapy: The First In- Human Megavoltage-Topogram Acquisition. (2016) (0)
Quality of Life Outcomes from a Phase I/II Multi-institutional, Dose-per-Fraction Escalation Trial for Prostate Cancer (2014) (0)
Clinical experience with a PET/CT scanner to account for intrafraction motion in radiation oncology (2008) (0)
Development of Anatomic Site-Specific Item Sets for Acute Toxicity Assessment in Radiation Oncology Using the US National Cancer Institute PRO-CTCAE (2015) (0)
SU-F-BRB-13: Correlation of Improved Target and Organ-At-Risk Dosimetric Quantities and Clinical Outcomes for Helical Tomotherapy Treated Mesothelioma (2015) (0)
Treatment of Favorable-Risk Prostate Cancer (2011) (0)
Combined Chemotherapy and Radiation Results in Improved Outcomes in High-Risk Endometrial Cancer Patients (2012) (0)
2478: Stability of Implanted Fiducials for X-Ray Localization of Lung Tumors During Radiation Therapy (2006) (0)
SU‐DD‐A3‐03: A Dose‐Guided Adaptive Therapy Process for Treatment Evaluation and Correction (2006) (0)
A database paradigm for the management of DICOM-RT structure sets using a geographic information system (2014) (0)
Improved Biochemical Relapse-Free Survival With Early Salvage Radiation Therapy After Prostatectomy (2007) (0)
IMPLANTATION AND STABILITY OF FIDUCIAL MARKERS FOR STEREOTACTIC RADIOSURGERY (2007) (0)
SU‐FF‐J‐86: Prostate Movement During Radiation Therapy Delivery (2007) (0)
43 Short-course intensity modulated radiotherapy for localized prostate cancer with daily transabdominal ultrasound localization of the prostate gland: Technique, acute toxicity, and early observations (1999) (0)
Development of a Clinical Information Management System With Logical Organization for Improved Accuracy and Inheritance (2014) (0)
Prediction of Long-term Clinical Dose Response for Early-Stage Breast Cancer Using a Dual-Compartment Mathematical Model (2015) (0)
Sequencing of short course androgen deprivation and high-dose external beam radiotherapy for unfavorable localized prostate cancer: adjuvant or neoadjuvant (2002) (0)
Equivalent Uniform Dose (Eud) Is a Predictor of Acute Rectal Toxicity in Patients with Prostate Cancer Treated with Intensity Modulated Radiotherapy: P044 (2003) (0)
Increasing Radiation Doses Decrease Local and Distant Failures in Patients With Localized Prostate Cancer (2007) (0)
Do Targeted Ultrasound/MRI Fusion Biopsies Significantly Change Maximum Prostate Gleason Score Compared With Systematic Biopsies? (2013) (0)
Re: Linden RA et al.: Technique of outpatient placement of intraprostatic fiducial markers before external beam radiotherapy (Urology 2009;73:881-886). (2010) (0)
MO‐D‐M100F‐02: Latest Clinical Development for GU (2007) (0)
Dosimetric Comparison Between an MRI-Guided Tri-Cobalt-60 Teletherapy System and VMAT for Liver SBRT (2014) (0)
Moderately hypofractionated radiotherapy for localized prostate cancer: Long-term outcomes for 854 consecutive patients treated over 10 years (70 Gy in 2.5 Gy/fraction). (2019) (0)
SU-FF-T-131: Assessing the Dosimetric Impact of Intra-Fraction Prostate Motion On Step-And-Shoot IMRT Plans (2009) (0)
Investigation of Radiation Therapy Response Enhancement of DC Magnetic Fields (2012) (0)
SU‐FF‐J‐53: Evaluation of Image‐Guidance Strategies in the Treatment of Localized Prostate Cancers (2007) (0)
Outcomes of Stereotactic Body Radiation Therapy Delivered by Gantry-Based Linear Accelerators for Low and Intermediate-Risk Prostate Adenocarcinoma: A Multi-institutional Study (2018) (0)
Stereotactic Radiation Therapy Demonstrates Improved Tumor Control Versus Whole Brain Radiation Therapy in Breast Cancer Brain Metastasis for All Receptor Subtypes (2014) (0)
Positive resection margins following prostatectomy: Outcomes with and without radiation (2004) (0)
139 : In-Vivo Comparison of an Electromagnetic System to Standard kV X-Rays for Treatment Setup During External Beam Radiotherapy of Patients With Prostate Cancer (2006) (0)
MO-A-137-05: Assessment and Prediction of Treatment Plan Quality Through Integrated Planning Script. (2013) (0)
Targeted Biopsies Provide a More Accurate Representation of Gleason Score and Prostate Cancer Tumor Volume Compared with Standard Systematic Biopsies (2014) (0)
Exploring Value From the Patient’s Perspective Between Stereotactic Body Radiation Therapy, Intensity Modulated Radiation Therapy, and High-Dose-Rate Brachytherapy for Localized Prostate Cancer (2016) (0)
SU-E-T-657: Prostate Robotic Radiotherapy On Conventional C-Arm Linacs. (2013) (0)
Daily Megavoltage CT Imaging in Patients with Prostate Cancer Receiving Postoperative Radiation Therapy: Does the Prostate Bed Move? (2005) (0)
IMRT Planning for Head and Neck Cancers: Sparing of the Larynx in Helical Tomotherapy Treatment Plans (2007) (0)
432 Loose Pitch and Static Delivery Capabilities for Helical Tomotherapy (2005) (0)
Cost-Effectiveness of Conventionally-Fractionated, Hypofractionated, and Ultra-Hypofractionated Radiotherapy for Intermediate-Risk Prostate Cancer (2020) (0)
Do Pretreatment Immune Profiles Predict for Tumor Control, Survival and Toxicity in Stage I Non-Small Cell Lung Cancer (NSCLC) Patients Treated With SBRT? (2015) (0)
The intraprostatic immune environment after stereotactic body radiotherapy is dominated by myeloid cells (2020) (0)
Radiation therapy in the management of breast cancer brain metastases: the impact of receptor status on treatment response, intracranial recurrence, and survival (2016) (0)
WE‐D‐I‐6B‐08; Deformable Registration of the Planning Image (KVCT) and Daily Treatment Images (MVCT) for Adaptive Radiation Therapy (2005) (0)
Racial Disparity in Treatment Outcomes for Men with High-Risk Prostate Cancer in the Modern Era – A SEER-Medicare Linked Database Analysis (2018) (0)
SU‐FF‐T‐176: Dose Verification in Moving Targets During Helical Tomotherapy Beam Delivery (2006) (0)
High-Dose Radiation to the Subventricular Zone Does Not Alter the Patterns of Recurrence in GB (2014) (0)
2753: Feasibility of Image-Guided Helical Tomotherapy for Frame-Based Stereotactic Radiosurgery (2006) (0)
Comparison of Two Fractionation Schedules for Conformal Radiation Therapy for Prostate Cancer (2005) (0)
TH‐C‐J‐6B‐04: Performance Characterization of Megavoltage CT Imaging On a Helical Tomotherapy Unit (2005) (0)
Biochemical Relapse-Free Survival After High Dose External Radiotherapy (≥78Gy) and 6 Months of Androgen Deprivation in High-Risk Localized Prostate Cancer Patients (2005) (0)
Changing Definitions of Biochemical Failure After External Beam Radiotherapy for Localized Prostate Cancer: Effect on Outcome Analyses (2005) (0)
WE‐E‐BRB‐01: Impact Or No Impact of Respiratory Motion On Helical Tomotherapy Dose Delivery (2009) (0)
In response to Dr. Kwan et al. (2002) (0)
Feasibility study for the treatment of metastatic prostate cancer with the radioactive antiandrogen I-125-bicalutamide (=I-125-casodex) (2000) (0)
Promises and Pitfalls: Development of a National Brachytherapy Registry (2014) (0)
No difference in biochemical failures with or without pelvic lymph node dissection during radical prostatectomy Preliminary results (1999) (0)
Combined Pretreatment Serum Testosterone Concentration and Risk Stratification Enhances Interpretation of Prostate-Specific Antigen (PSA) Kinetics in Localized Prostate Cancer After Stereotactic Body Radiation Therapy (SBRT) (2016) (0)
Racial Disparities in Prostate Cancer–Specific Survival After Definitive Treatment for Gleason 8-10 Localized Prostate Cancer (2016) (0)
Phase I Trial of Stereotactic Body Radiotherapy Neoadjuvant to Radical Prostatectomy for Patients with Unfavorable and High-Risk Non-Metastatic Prostate Cancer: Feasibility And Safety (2019) (0)
A Dosimetric Study of Inhomogeneous Dose Delivery: A Novel Approach to Dose Escalation (2011) (0)
2225 : Urinary and Bowel Toxicity After External Beam Radiotherapy for Localized Prostate Cancer: Correlation of Acute Versus Late Toxicities (2006) (0)
SU‐E‐T‐01: (In)dependence of Plan Quality On Treatment Modalities and Target‐To‐Critical Structure Geometry for Brain Tumor (2015) (0)
IN REGARD TO KUPELIAN ET AL. Author's reply (2008) (0)
Impact of biochemical failure on overall survival within ten years after radiotherapy for localized prostate cancer (2000) (0)
PSA Bounce after HDR Monotherapy for Prostate Cancer: Magnitude, Kinetics and Clinical Correlates (2011) (0)
SU‐FF‐J‐25: An Optimized Dose‐Based Patient Alignment Method for On‐Line Adaptive Radiotherapy (2006) (0)
Long-term clinical and toxicity outcomes of hypofractionated intensity-modulated radiation therapy for clinically localized prostate cancer. (2014) (0)
Pooled Analysis of High-Dose-Rate Brachytherapy or Stereotactic Body Radiation Therapy Monotherapy for Intermediate-Risk Prostate Cancer (2015) (0)
1886: Has PSA-Induced Stage Migration Ended? (2007) (0)
Long Term Outcomes With High Dose External Beam Radiation Therapy (EBRT) and Short Term Androgen Deprivation in Localized High Risk Prostate Cancer (2007) (0)
1611: Familial Prostate Cancer: Is it More Aggressive or is it Not? (2006) (0)
Patient-specific Quantification of the Dosimetric Impact of Motion During Radiation Therapy: A Clinically Usable Tool (2012) (0)
In response to Dr. Halperin (2005) (0)
1452: Defining the Characteristics of Locally Recurrent Prostate Cancer After Radical Prostatectomy Based on the Results of Salvage Radiotherapy: a Multi-Center Analysis (2004) (0)
SU-F-BRF-01: A GPU Framework for Developing Interactive High-Resolution Patient-Specific Biomechanical Models. (2014) (0)
Diffusion Weighted Imaging and the Attenuation Diffusion Coefficient Value as a Possible Imaging Biomarker in Cervical Cancer: Correlation With Baseline Patient Characteristics (2015) (0)
2765 : An On-line Dose Guided Adaptive Approach for Prostate Patient Positioning (2006) (0)
PO-0722: Dosimetric parameters correlated to quality of life after stereotactic body radiation therapy for prostate cancer (2014) (0)
1054 : Comparison of Megavoltage CT Image-Based Volumetric Dose Calculations With ICRU Reference Point Estimates of Bladder and Rectal Doses During Low Doserate Intracavitary Brachytherapy for Cervical Cancer (2006) (0)
2085 Model-Based Prediction of Biochemical Failure in Prostate Cancer Patients Following Radiation Therapy (2002) (0)
SU‐FF‐T‐175: Dosimetric Effect of Rotational Variation On Helical Tomotherapy Treatment Plans (2007) (0)
A provider-based quality improvement intervention aimed at improving appropriateness of radiation therapy regimens for patients with advanced cancer and painful bone metastases. (2016) (0)
1022 Indications for seminal vesicle coverage in the treatment of clinically localized adenocarcinoma of the prostate with radiotherapy alone (1995) (0)
WE‐E‐BRC‐11: Towards Subject Specific Head and Neck Biomechanical Models Using Multi‐Level Multi‐Resolution and Inverse Consistent Registration Algorithms for Radiotherapy (2011) (0)
1186: 10-year Single Institution Non-Randomized Comparison of Biochemical Outcomes After Radical Prostatectomy and External Beam Radiotherapy for Clinically Localized Prostate Cancer (2004) (0)
2158 Unfavorable localized prostate cancer: Radiotherapy versus surgery, androgen deprivation versus no androgen deprivation, high versus low radiation doses? (1999) (0)
Exploring the patient’s perspective of value with SBRT, IMRT, or HDR brachytherapy for localized prostate cancer (2016) (0)
Parameters affecting overall survival after external beam radiotherapy for localized prostate cancer in the Psa era (2002) (0)
Declining R ates o f E xtracapsular E xtension A fter R adical Prostatectomy: E vidence f or C ontinued S tage M igration (1999) (0)
Considerations for quality improvement in radiation oncology therapy for patients with uncomplicated painful bone metastases. (2014) (0)
Biochemical relapse-free survival rates after external beam radiotherapy for clinical stage T1–T3 prostate cancer in the PSA era: what should we expect (2002) (0)
SU‐FF‐J‐80: Real‐Time Visualization of Radiation Dose Accumulation in Lung Tumors (2007) (0)
TH-C-T-6C-05: Evaluation of TomoTherapy's MVCT Number Integrity (2005) (0)
Computational Fluid Dynamics Modeling of Airflow inside Lungs Using Heterogenous Anisotropic Lung Tissue Elastic Properties (2012) (0)
SU‐FF‐J‐19: Adaptive Radiation Therapy Using Helical Tomotherapy (2006) (0)
SU-E-T-214: Predicting Plan Quality from Patient Geometry: Feature Selection and Inference Modeling. (2012) (0)
Daily Dose Recalculation Using Megavoltage CT Images During Tomotherapy for Localized Prostate Cancer: Dosimetric Analysis for the Prostate Gland, Rectum and Bladder for the Full Treatment Course (2005) (0)
197 Efficacy of local therapies for localized prostate cancer in the PSA era (1987–1998): A large single institution experience with radical prostatectomy and external beam radiotherapy (1999) (0)
Estimation of lung tumor dosimetry through mathematical modeling of respiratory-gated computed tomography imaging (2008) (0)
Relapse-free survival after either high-dose intensity-modulated radiation therapy or permanent seed implantation for localized prostate cancer: Any difference (2004) (0)
SU‐FF‐J‐59: Evaluation of Daily Tumor Localization Shifts in the H&N Region Based On Bony Anatomy and Soft‐Tissue Implanted Markers (2007) (0)
Investigating Dynamic Radiation Dose Accumulation for Non-small Cell Lung Cancer Patients using Optical Flow Analysis of Repeat-4DCT Imaging and GPU Based Dose Computation (2009) (0)
Feasibility of MRI-Guided Tri-Cobalt-60 IMRT for Preoperative Radiation therapy of Soft-Tissue Sarcomas (2014) (0)
Cardiovascular Blood Flow Analysis Under Normal and Open Injury Conditions (2014) (0)
Superficial X-ray Therapy for Non-Melanoma Skin Cancer of the Head and Neck: Comparative Analysis of H-Zone Versus Non-H-Zone Lesions (2015) (0)
SU‐EE‐A3‐05: Accuracy Testing of Deformable Registration Using Dosimetric End‐Points (2006) (0)
SU-D-BRD-04: A Logical Organizational Approach to Clinical Information Management. (2014) (0)
Title Focal high-dose-rate brachytherapy : A dosimetric comparison of hemigland vs . conventional whole-gland treatment Permalink (0)
Feasibility of Margin Reduction for Level II and III Planning Target Volume in Head-and-Neck Image Guided Radiation Therapy (2013) (0)
Treating Glioblastoma Multiforme as a Chronic Disease: Mathematical Dose Fractionation Schedule Optimization and Modeling With Cancer Stem Cell Dynamics (2015) (0)
The intraprostatic immune balance after prostate SBRT in patients. (2020) (0)
9 Prostate Cancer Radiation Therapy Conventional Conformal and Brachytherapy (0)
SU-E-T-696: Registry Based Framework for Plan Quality Improvement: A Head-And-Neck Radiotherapy Application Improving Simultaneous Integrated Boost Treatments. (2013) (0)
Peripheral Zone Prostate Cancer Lesions on Diffusion Weighted Imaging MRI Show Different Correlations with Gleason Score, NCCN Risk and Tumor Size than Central Lesions (2014) (0)
2156 Decreasing extracapsular rates and improving outcome in the PSA ERA: Continued stage migration independent from pretreatment PSA and clinical stage (1999) (0)
Short-course intensity modulated radiotherapy (70 gy at 2.5 gy per fraction) for localized prostate cancer: late toxicity and quality of life (2001) (0)
Evaluating Prostate-Specific Antigen (PSA) Nadir and Bounce After Stereotactic Body Radiotherapy (SBRT) in a Multi-Institutional Cohort (2019) (0)
MO-C-17A-03: A GPU-Based Method for Validating Deformable Image Registration in Head and Neck Radiotherapy Using Biomechanical Modeling. (2014) (0)
Younger Age but Not Receptor Status May Predispose to Radiation Necrosis in Radiation Therapy for Breast Cancer Brain Metastasis (2015) (0)
TH-C-M100J-03: Lung Localization and Initial Shifts Based On Implanted Markers (2007) (0)
TU-CD-304-05: 4Ï€ Non-Coplanar Radiotherapy: From Mathematical Modeling to Clinical Implementation (2015) (0)
The dosimetric effect of intrafraction prostate motion on step-and-shoot IMRT plans – magnitude, correlation with motion parameters, and comparison with helical tomotherapy plans (2012) (0)
1094 High dose radiation therapy with intensity modulated radiation therapy (IMRT) improves outcomes in localized prostate cancer. A large single institution experience (2003) (0)
WE‐AB‐BRA‐10: Systematic Assessment of a Novel Image Similarity Parameterization Metric for Fully Automated Quantification of Deformable Image Registration Accuracy (2015) (0)
Implications of Accurate Determination of Gleason Scores in Localized Prostate Cancer Patients Treated with Radiation: Are Routine Biopsies Adequate for Accurate Risk Stratification? (2009) (0)
Changes in Early Urination Control in Relation to Stereotactic Body Radiation Therapy for Localized Prostate Cancer Patients: Comparison With a Community-Based Cohort (2015) (0)
Pretreatment N omogram T hat P redicts 5 -Year P robability o f Metastasis F ollowing T hree-Dimensiona l C onformal R adiation Therapy f or L ocalized P rostate C ancer (2003) (0)
The proportion of biopsy cores positive for cancer is an independent predictor of prostate cancer volume and early biochemical failure after radiotherapy (2003) (0)
A Prospective Multi-institutional Phase I/II Trial of Step-wise Dose-per-Fraction Escalation in Low and Intermediate Risk Prostate Cancer. (2020) (0)
Dosimetric Parameters Predict Quality of Life Outcomes for Patients Receiving Stereotactic Body Radiation Therapy for Prostate Cancer (2014) (0)
Image-Guided Hypofractionated Radiation Therapy with Stereotactic Boost for Inoperable Stage III Non-Small Cell Lung Cancer (2012) (0)
Pretreatment N omogram f or P redicting t he O utcome of T hree-Dimensiona l C onformal R adiotherapy i n Prostate C ancer (2000) (0)
Collection of Treatment Plan Parameters and Related Quality Indices Into Radiation Therapy Registries (2012) (0)
A Dosimetric Evaluation of Markers vs. Bony Anatomy Alignments for a Head and Neck Case (2007) (0)
Treatment of Trigeminal Neuralgia With Linac Based Radiosurgery in Patients With Multiple Sclerosis (2015) (0)
1136: Which Definition of Biochemical Failure after Post-Operative Radiotherapy Predicts Best for Clinical Failure? A Multi-Institutional Analysis (2005) (0)
SU‐FF‐T‐13: A Fast Scan‐Plan‐Treat Mode for Topographic Breast Treatment Delivery (2006) (0)
Clinical Experience with 4D PET/CT to Account for Intrafraction Motion in Radiation Oncology (2008) (0)
1042: Pretreatment PSA Levels as Predictors of Overall Survival After Prostatectomy or Radiotherapy for Localized Prostate Cancer (2004) (0)
Comparison of the Efficacy of Local Therapies for Local ized Prostate Cancer in the Prostate -Specific Ant igen (2016) (0)
IGRT: How and When (2014) (0)
In response to Dr. Lee (2000) (0)
TU-C-17A-01: A Data-Based Development for Pratical Pareto Optimality Assessment and Identification. (2014) (0)
Plan Quality and Dosimetric Association of Acute and Late Rectal and Urinary Toxicities for Prostate Stereotactic Body Radiotherapy (2014) (0)
SU‐E‐T‐29: Workflow and Data Architecture Paradigm for Building a Large Scale Dose‐Volume Registry (2011) (0)
Ten-Year Outcomes and Toxicity with Moderately Hypofractionated (70 Gy in 28 fractions) Intensity-Modulated Radiation Therapy for Localized Prostate Cancer. (2018) (0)
SU-E-J-127: Real-Time Dosimetric Assessment for Adaptive Head-And-Neck Treatment Via A GPU-Based Deformable Image Registration Framework. (2014) (0)
SU-E-J-58: Patient-Specific Biomechanical Head and Neck Models for Interfraction Dose Accumulation. (2012) (0)
A new generalized meshless method technique for tracheobronchial airflow modeling (2010) (0)
45 Familial prostate cancer has a more aggressive course than sporadic prostate cancer after treatment for localized disease, mainly due to a higher rate of distant metastases (1997) (0)
Serial Megavoltage CT Imaging For Non-Small Cell Lung Cancer: Observations on Tumor Regression During Treatment (2005) (0)
Competing Risk Analysis for Causes of Death in Men With High-Risk Prostate Cancer (2012) (0)
THE RELATIONSHIP BETWEEN PROSTATE SIZE AND BIOCHEMICAL PROGRESSION-FREE SURVIVAL IN PATIENTS WITH PROSTATE CANCER (2008) (0)
Abstracts of the 2007 Young Invesigators Symposium (2007) (0)
Association between a CYP3A4Genetic Variant and Clinical Presentation in African-American Prostate Cancer Patients (2000) (0)
Focal Stereotactic Body Radiation Therapy for Prostate Cancer: A Dosimetric Comparison Between Whole and Hemi-Gland Treatment (2013) (0)
Clinical Outcomes for Patients With Gleason Score 9-10 Prostate Adenocarcinoma Treated With Radiation Therapy or Radical Prostatectomy: A Comparative Analysis (2016) (0)
1013 Conformal radiotherapy versus short-course intensity modulated radiotherapy for localized prostate cancer with daily transabdominal ultrasound localization of the prostate gland: Dosimetry and acute toxicity (1999) (0)
Long-term (potential 10 year follow-up) Toxicity after Treatment for Prostate Cancer with Either External Beam Radiation Therapy, Interstitial Brachytherapy, or Radical Prostatectomy (2010) (0)
Pretreatment Markers of Systemic Inflammation and Outcomes With Stereotactic Radiosurgery for Brain Metastases (2016) (0)
Hypofractionated Stereotactic Radiotherapy for Stage III Non-small Cell Lung Cancer: A Dosimetric Feasibility Study (2011) (0)
Predictive Adaptive Radiation Therapy for Lung Cancer (2007) (0)
2211 : Concomitant Irradiation of the Entire Prostate Gland to 70 Gy and the Peripheral Zone to 80 Gy with Intensity Modulated Radiotherapy in 28 Fractions: Preliminary Results of a Phase II Protocol (2006) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With Patrick A. Kupelian?

Patrick A. Kupelian is affiliated with the following schools:

University of California, Los Angeles
University of Helsinki

Patrick A. Kupelian's Academic­Influence.com Rankings

Why Is Patrick A. Kupelian Influential?

Patrick A. Kupelian's Published Works

Published Works

What Schools Are Affiliated With Patrick A. Kupelian?

Patrick A. Kupelian's AcademicInfluence.com Rankings